Evaluating the performance of PI-RADS v2 in the non-academic setting.

about

Evaluating the performance of PI-RADS v2 in the non-academic setting.

Item

http://www.wikidata.org/entity/Q38815543

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Evaluating the performance of PI-RADS v2 in the non-academic setting.

@en

type

Item

label

Evaluating the performance of PI-RADS v2 in the non-academic setting.

@en

prefLabel

Evaluating the performance of PI-RADS v2 in the non-academic setting.

@en

P1476

Evaluating the performance of PI-RADS v2 in the non-academic setting.

@en

P2093

Antonio C Westphalen

http://www.w3.org/2001/XMLSchema#string

Charles Fiske

http://www.w3.org/2001/XMLSchema#string

Eric J Jordan

http://www.w3.org/2001/XMLSchema#string

Ronald J Zagoria

http://www.w3.org/2001/XMLSchema#string

P2860

Prostate MRI based on PI-RADS version 2: how we review and report

Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence

Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales.

Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.

Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis.

Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference

Prostate Imaging Reporting and Data System (PI-RADS), Version 2: A Critical Look.

Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients.

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients.

P2888

s00261-017-1169-5

P31

scholarly article

P356

10.1007/S00261-017-1169-5

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28451763

http://www.w3.org/2001/XMLSchema#string